Top Markets
#1 Nesa Nesa +804.64%
#2 Cortex Cortex +68.53%
#3 Kinesis Silver Kinesis Silver +55.47%
#4 QuantixAI QuantixAI +23.95%
#5 EXOD EXOD +22.78%
#6 Alchemist AI Alchemist AI +20.66%
#7 Cash Cat Cash Cat +20.55%
#8 Pons Pons +18.96%
#9 OpenEden OpenEden +13.89%
#10 BCGame Coin BCGame Coin +13.88%
Coin of the day
Nesa Nesa
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Definium Therapeutics, Inc. Definium Therapeutics, Inc.

Definium Therapeutics, Inc.

DFTX
Classement en actions #3217
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm... Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.
Prix de l'action
$44.42
Dernière synchronisation: 2026-08-25
Capitalisation boursière
$5.90B
Changement (1 jour)
2.66%
Changement (1 an)
344.66%
Pays
US
Échange Definium Therapeutics, Inc. (DFTX)

Catégorie

Healthcare
Ratio P/S pour Definium Therapeutics, Inc. (DFTX)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Definium Therapeutics, Inc., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Definium Therapeutics, Inc. de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH